Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 32 checked references that resolve
resolves10.1371/journal.pmed.1001388Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries
resolves10.1056/NEJM200011233432103Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
resolves10.1056/NEJMoa050405Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
resolves10.1016/S0140-6736(06)69666-9Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
resolves10.1093/rheumatology/kei049The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition
resolves10.1038/srep39672Osteoarthritis and the risk of cardiovascular disease: a meta-analysis of observational studies
resolves10.1136/bmj.j1909Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
resolves10.1002/cpt.696Coxibs, Traditional NSAIDs, and Cardiovascular Safety Post‐PRECISION: What We Thought We Knew Then and What We Think We Know Now
resolves10.1111/bcpt.13059Basic & Clinical Pharmacology & Toxicology Policy for Experimental and Clinical studies
resolves10.7326/M13-1581Relation of Nonsteroidal Anti-inflammatory Drugs to Serious Bleeding and Thromboembolism Risk in Patients With Atrial Fibrillation Receiving Antithrombotic Therapy
resolves10.1371/journal.pmed.1001098Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
resolves10.1161/CIRCULATIONAHA.107.720847Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk
resolves10.2147/CLEP.S91125The Danish National Patient Registry: a review of content, data quality, and research potential
resolves10.1016/j.jacc.2014.03.039Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease
resolves10.1002/pds.1200Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics
resolves10.1172/JCI27291Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
resolves10.1161/01.CIR.0000124715.27937.78Clinical Pharmacology of Platelet, Monocyte, and Vascular Cyclooxygenase Inhibition by Naproxen and Low-Dose Aspirin in Healthy Subjects
resolves10.1016/j.clinthera.2011.10.019Patterns of Therapy Switching, Augmentation, and Discontinuation After Initiation of Treatment With Select Medications in Patients With Osteoarthritis
resolves10.1002/pds.653Drug switching patterns among patients taking non‐steroidal anti‐inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom
resolves10.1136/gut.52.9.1265Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs
resolves10.1136/bmj.332.7553.1302Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
resolves10.1016/j.ahj.2008.12.014Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis
resolves10.1016/S0140-6736(13)60900-9Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
The 3 references without a DOI — listed, not checked
no DOI — not checkedRytgaardH.C. GerdsT.A.From %x_recepter to Rcpp: a mathematical formulation of the algorithm a new R‐user interface and an efficient implementation [Internet]. Available from:https://github.com/tagteam/heaven/blob/master/worg/medicin-macro.pdf.
no DOI — not checkedChouR McDonaghMS NakamotoE GriffinJ.Analgesics for Osteoarthritis: An Update of the 2006 Comparative Effectiveness Review [Internet].Rockville MD:Agency for Healthcare Research and Quality (US);2011[cited 2018 Dec 5]. Available from:http://www.ncbi.nlm.nih.gov/books/NBK65646/
no DOI — not checkedRandomized trial of switching from prescribed non‐selective non‐steroidal anti‐inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.